Coloplast A/S (CBHD.DE) Stock Analysis & Winston Score
Coloplast is a Danish medical device company that makes products for people with intimate health conditions — things like ostomy bags (for people who have had bowel surgery), catheters, wound care supplies, and continence products. Its customers are mostly patients, hospitals, and home care providers across the healthcare system. Coloplast is one of the largest companies in the world focused specifically on these types of personal medical needs. The company sells its products directly to healthcare systems and through distributors, earning revenue from ongoing product purchases rather than one-time sales — patients typically need these supplies for life. Coloplast operates in over 40 countries, with Europe as its largest market and the United States as a key growth region, generating roughly $3 billion in annual revenue. Its main competitive advantages are strong brand loyalty among clinicians and patients, and deep specialization in a niche that larger medical device companies tend to avoid — though currency fluctuations and pricing pressure from healthcare systems remain ongoing risks.
Winston Score: 58/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Strong (25/30)
- Growth: Weak (2/20)
- Cash Flow: Good (6/10)
- Stability: Good (6/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: €58.66
Market Cap: €13.2B
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: Frankfurt Stock Exchange


